UnknownPhase 3NCT03800524
Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Humanitas Mirasole SpA
- Principal Investigator
- Alberto Albanese, MDHumanitas Mirasole SpA
- Intervention
- Tauroursodeoxycholic Acid(drug)
- Enrollment
- 337 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2019 – 2023
Study locations (25)
- Katholieke Universiteit Leuven, Leuven, Belgium
- Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
- Centre Hospitalier Universitaire Limoges, Limoges, France
- Centre Hospitalier Universitaire de Montpellier, Montpellier, France
- Centre Hospitalier Regional Universitaire de Tours, Tours, France
- Charité - Universitätsmedizin Berlin, Berlin, Germany
- Universitätsklinikum Carl Gustav Carus Dresden, Dresden, Germany
- Alfried Krupp Krankenhaus Rüttenscheid, Essen, Germany
- Medizinische Hochschule Hannover, Hanover, Germany
- Universitätsklinikum Jena, Jena, Germany
- Universität Ulm, Ulm, Germany
- Trinity College Dublin, Dublin, Ireland
- IRCCS Istituto Auxologico Italiano, Milan, Italy
- NEuroMuscular Omnicentre. Fondazione Serena Onlus, Milan, Italy
- AOU Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy
- +10 more locations on ClinicalTrials.gov
Collaborators
University of Ulm · University of Sheffield · University Hospital, Tours · KU Leuven · UMC Utrecht · University of Dublin, Trinity College · Bruschettini S.r.l. · Istituto Superiore di Sanità · Motor Neurone Disease Association · European Commission
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03800524 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07259980A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)Biogen
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)